{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T18:56:42Z","timestamp":1785783402311,"version":"3.56.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,3,14]],"date-time":"2020-03-14T00:00:00Z","timestamp":1584144000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,3,14]],"date-time":"2020-03-14T00:00:00Z","timestamp":1584144000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diagn Pathol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Malignant eccrine spiradenoma is one of the rarest sweat-gland tumors. Here, we describe a rare case of low grade malignant eccrine spiradenoma located at the vulva.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Case presentation<\/jats:title>\n<jats:p>The vulvar lesion was described as a mass measured 3.5\u2009cm and located in the dermis and subcutis with no attachment to the epidermis. The neoplasm was arranged in ragged sheets or solid nodules sometimes with focal necrosis. The tumor cells had hyperchromatism, pleomorphism, and prominent nucleoli with high mitotic index and KI-67 estimated at 70\u201380%.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>It\u2019s only the fifth case of malignant eccrine spiradenoma localized at the vulva. This is the first time that an HPV genotyping was made in this type of lesion with no HPV found while the p16 expression was diffuse. Moreover, it\u2019s the first time that a p53 mutation is detected by sequencing in this location.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s13000-020-00945-9","type":"journal-article","created":{"date-parts":[[2020,3,14]],"date-time":"2020-03-14T01:03:01Z","timestamp":1584147781000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Low grade malignant eccrine spiradenoma of the vulva: case report, review of the literature and discussion about the role of p53 and HPV"],"prefix":"10.1186","volume":"15","author":[{"given":"Xavier","family":"Catteau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicky","family":"D\u2019haene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Christophe","family":"No\u00ebl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,14]]},"reference":[{"key":"945_CR1","first-page":"388","volume":"11","author":"M Dabska","year":"1972","unstructured":"Dabska M. Malignant transformation of eccrine spiradenoma. Pol Med J. 1972;11:388\u201396.","journal-title":"Pol Med J"},{"key":"945_CR2","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.amjsurg.2010.04.015","volume":"201","author":"MT Andreoli","year":"2011","unstructured":"Andreoli MT, Itani KM. Malignant eccrine spiradenoma: a meta-analysis of reported cases. Am J Surg. 2011;201:695\u20139.","journal-title":"Am J Surg"},{"key":"945_CR3","volume-title":"Rare Malignant Skin Tumors","year":"2015","unstructured":"Rongioletti F, et al., editors. Rare Malignant Skin Tumors. New York: Springer; 2015."},{"key":"945_CR4","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1111\/j.1600-0560.2009.01320.x","volume":"37","author":"E Ben Brahim","year":"2010","unstructured":"Ben Brahim E, Sfia M, Tangour M, Makhlouf R, Cribier B, Chatti S. Malignant eccrine spiradenoma: a new case report. J Cutan Pathol. 2010;37:478\u201381.","journal-title":"J Cutan Pathol"},{"key":"945_CR5","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1097\/DAD.0000000000000910","volume":"39","author":"RD Staiger","year":"2017","unstructured":"Staiger RD, Helmchen B, Papet C, Mattiello D, Zingg U. Spiradenocarcinoma: A Comprehensive Data Review. Am J Dermatopathol. 2017;39:715\u201325.","journal-title":"Am J Dermatopathol"},{"key":"945_CR6","doi-asserted-by":"crossref","first-page":"591","DOI":"10.5858\/2002-126-0591-MES","volume":"126","author":"I Mirza","year":"2002","unstructured":"Mirza I, Kloss R, Sieber SC. Malignant eccrine spiradenoma. Arch Pathol Lab Med. 2002;126:591\u20134.","journal-title":"Arch Pathol Lab Med"},{"key":"945_CR7","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1001\/archderm.1985.01660110093023","volume":"121","author":"PH Cooper","year":"1985","unstructured":"Cooper PH, Frierson HF, Morrison AG. Malignant transformation of eccrine spiradenoma. Arch Dermatol. 1985;121:1445\u20138.","journal-title":"Arch Dermatol"},{"key":"945_CR8","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1097\/00000372-199008000-00002","volume":"12","author":"PH McKee","year":"1990","unstructured":"McKee PH, Fletcher CD, Stavrinos P, Pambakian H. Carcinosarcoma arising in eccrine spiradenoma. A clinicopathologic and immunohistochemical study of two cases. Am J Dermatopathol. 1990;12:335\u201343.","journal-title":"Am J Dermatopathol"},{"key":"945_CR9","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1111\/pde.12136","volume":"32","author":"JR Miedema","year":"2015","unstructured":"Miedema JR, Burgon E, Burkhart C, Stitzenberg K, Hipps J, Zedek D. Metastatic spiradenocarcinoma occurring in an 8-year-old boy. Pediatr Dermatol. 2015;32:122\u20137.","journal-title":"Pediatr Dermatol"},{"key":"945_CR10","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1067\/mjd.2001.107471","volume":"44","author":"MJ Fern\u00e1ndez-Ace\u00f1ero","year":"2001","unstructured":"Fern\u00e1ndez-Ace\u00f1ero MJ, Manzarbeitia F, Mestre de Juan MJ, Requena L. Malignant spiradenoma: report of two cases and literature review. J Am Acad Dermatol. 2001;44:395\u20138.","journal-title":"J Am Acad Dermatol"},{"key":"945_CR11","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1136\/ijgc-00009577-200605000-00083","volume":"16","author":"DM Chase","year":"2006","unstructured":"Chase DM, Basu T, Saffari B, Ries S, Berman ML. Malignant eccrine spiradenoma of the vulva: a case report and review of the literature. Int J Gynecol Cancer. 2006;16:1465\u20139.","journal-title":"Int J Gynecol Cancer"},{"key":"945_CR12","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.5858\/arpa.2012-0434-OA","volume":"137","author":"GM Baker","year":"2013","unstructured":"Baker GM, Selim MA, Hoang MP. Vulvar adnexal lesions: a 32-year, single-institution review from Massachusetts General Hospital. Arch Pathol Lab Med. 2013;137:1237\u201346.","journal-title":"Arch Pathol Lab Med"},{"key":"945_CR13","first-page":"1229","volume":"33","author":"EE Emam","year":"2012","unstructured":"Emam EE, Sawan AS, Al-Tamimi SR, Molah RM. Malignant spiradenoma\/cylindroma of the vulva. Saudi Med J. 2012;33:1229\u201333.","journal-title":"Saudi Med J"},{"key":"945_CR14","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1097\/PGP.0b013e3182055a3d","volume":"30","author":"G Chen","year":"2011","unstructured":"Chen G, Cheuk W, Cheung JS, Chan JK. Carcinosarcoma ex eccrine spiradenoma of the vulva: report of the first case. Int J Gynecol Pathol. 2011;30:301\u20135.","journal-title":"Int J Gynecol Pathol"},{"key":"945_CR15","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s12282-007-0023-y","volume":"15","author":"Y Tanaka","year":"2008","unstructured":"Tanaka Y, Bhunchet E, Shibata T. A case of malignant eccrine spiradenoma metastatic to intramammary lymph node. Breast Cancer. 2008;15:175\u201380.","journal-title":"Breast Cancer"},{"key":"945_CR16","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1111\/j.1365-2230.2008.03072.x","volume":"35","author":"K Tanese","year":"2010","unstructured":"Tanese K, Sato T, Ishiko A. Malignant eccrine spiradenoma: case report and review of the literature, including 15 Japanese cases. Clin Exp Dermatol. 2010;35:51\u20135.","journal-title":"Clin Exp Dermatol"},{"key":"945_CR17","first-page":"290","volume":"68","author":"S Agarwal","year":"2002","unstructured":"Agarwal S, Khanna R, Arya NC, Khanna AK. Malignant eccrine spiradenoma: an unusual presentation. Indian J Dermatol Venereol Leprol. 2002;68:290\u20131.","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"945_CR18","first-page":"1189","volume":"32","author":"BM Hantash","year":"2006","unstructured":"Hantash BM, Chan JL, Egbert BM, Gladstone HB. De novo malignant eccrine spiradenoma: a case report and review of the literature. Dermatol Surg. 2006;32:1189\u201398.","journal-title":"Dermatol Surg"},{"key":"945_CR19","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1002\/jso.2930310105","volume":"31","author":"DM Morris","year":"1986","unstructured":"Morris DM, Sanusi ID, Lanehart WH. Carcinoma of eccrine sweat gland: experience with chemotherapy, autopsy findings in a patient with metastatic eccrine carcinoma, and a review of the literature. J Surg Oncol. 1986;31:26\u201330.","journal-title":"J Surg Oncol"},{"key":"945_CR20","first-page":"67","volume":"27","author":"M Ishikawa","year":"2001","unstructured":"Ishikawa M, Nakanishi Y, Yamazaki N, Yamamoto A. Malignant eccrine spiradenoma: a case report and review of the literature. Dermatol Surg. 2001;27:67\u201370.","journal-title":"Dermatol Surg"},{"key":"945_CR21","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1097\/00000372-200004000-00002","volume":"22","author":"SR Granter","year":"2000","unstructured":"Granter SR, Seeger K, Calonje E, Busam K, McKee PH. Malignant eccrine spiradenoma (spiradenocarcinoma): a clinicopathologic study of 12 cases. Am J Dermatopathol. 2000;22:97\u2013103.","journal-title":"Am J Dermatopathol"},{"key":"945_CR22","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1111\/j.1440-1827.2004.01609.x","volume":"54","author":"SC Chou","year":"2004","unstructured":"Chou SC, Lin SL, Tseng HH. Malignant eccrine spiradenoma: a case report with pulmonary metastasis. Pathol Int. 2004;54:208\u201312.","journal-title":"Pathol Int"},{"key":"945_CR23","volume-title":"Rubin\u2019s pathology","year":"2008","unstructured":"Rubin R, Strayer S, editors. Rubin\u2019s pathology. 5th ed. Philadelphia: Lippincott Williams & Wilkins; 2008.","edition":"5"},{"key":"945_CR24","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1111\/j.1365-2559.1995.tb00251.x","volume":"26","author":"W Biernat","year":"1995","unstructured":"Biernat W, Kordek R, Wo\u017aniak L. Over-expression of p53 protein as an indicator of the malignant transformation in spiradenoma. Histopathology. 1995;26:439\u201343.","journal-title":"Histopathology."},{"key":"945_CR25","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/DAD.0b013e3181b9678c","volume":"32","author":"DV Kazakov","year":"2010","unstructured":"Kazakov DV, Grossmann P, Spagnolo DV, et al. Expression of p53 and TP53 mutational analysis in malignant neoplasms arising in preexisting spiradenoma, cylindroma, and spiradenocylindroma, sporadic or associated with Brooke-Spiegler syndrome. Am J Dermatopathol. 2010;32:215\u201321.","journal-title":"Am J Dermatopathol"},{"key":"945_CR26","doi-asserted-by":"publisher","first-page":"191","DOI":"10.3346\/jkms.1998.13.2.191","volume":"13","author":"HH Lee","year":"1998","unstructured":"Lee HH, Lee KG. Malignant eccrine spiradenoma with florid squamous differentiation. J Korean Med Sci. 1998;13:191\u20135.","journal-title":"J Korean Med Sci"},{"key":"945_CR27","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1200\/JCO.2005.03.139","volume":"23","author":"YC Wang","year":"2005","unstructured":"Wang YC, Lin RK, Tan YH, Chen JT, Chen CY, Wang YC. Wild-type p53 overexpression and its correlation with MDM2 and p14ARF alterations: an alternative pathway to non-small-cell lung cancer. J Clin Oncol. 2005;23:154\u201364.","journal-title":"J Clin Oncol"},{"key":"945_CR28","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1136\/jclinpath-2018-205216","volume":"71","author":"S Serra","year":"2018","unstructured":"Serra S, Chetty R. J Clin Pathol. 2018;71:853\u20138.","journal-title":"J Clin Pathol"}],"container-title":["Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-020-00945-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13000-020-00945-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-020-00945-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,14]],"date-time":"2021-03-14T00:08:36Z","timestamp":1615680516000},"score":1,"resource":{"primary":{"URL":"https:\/\/diagnosticpathology.biomedcentral.com\/articles\/10.1186\/s13000-020-00945-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,14]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["945"],"URL":"https:\/\/doi.org\/10.1186\/s13000-020-00945-9","relation":{},"ISSN":["1746-1596"],"issn-type":[{"value":"1746-1596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,14]]},"assertion":[{"value":"7 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The case report protocol was approved by the institutional ethics and research review boards at Erasme Hospital. Patients signed a written informed consent upon admission to the hospital. Patients chose at admission whether to opt in or to opt out of providing consent, which affirms that physicians have the right to use patient\u2019s surplus biological material for research. Consent has been established by the local ethics committee (ethics committee Erasme-ULB) and is in accordance with Belgian and International law (Helsinki declaration).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Consent form will be sent if the case report is accepted.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"24"}}